IFIH1 and interstitial lung disease: In conclusion, in the treatment of anti-MDA5 antibody-positive associated interstitial lung disease, combined anticoagulation therapy can not only significantly improve pulmonary function and suppress the inflammatory response but also effectively reduce the incidence of complications and the risk of acute exacerbation, demonstrating important clinical application prospects.